← ANALYSTS · TIPRANKS
Julian Harrison · BTIG
Hits
57%
246 of 430 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+53.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
20
Buy / hold / sell: 20 / 0 / 0
Upside of the analyst’s targets
+265.4%
Average over 20 current targets, to the last price
The market’s answer to the ratings
+6.3%
Day-0 move against SPY in the rating’s direction, average over 8 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 14on TipRanks Oct 15 06:10 | RZLTIWMRezolute · $377M | Reiterated | Buy | $6.00 | +67.6% | −7.2%next day −8.1% | ↗ |
| Oct 14on TipRanks 06:10 | LQDAIWMLiquidia Technologies · $3.1B | Upgrade | Buy | $111 → $70.00−36.9% | +103.8% | +27.7%next day +2.2% | ↗ |
| Oct 9on TipRanks Oct 11 18:55 | NKTRIWMNektar Therapeutics · $1.3B | Reiterated | Buy | $178 | +397.5% | +0.3%next day −3.2% · 5 days −11.1% | ↗ |
| Oct 5on TipRanks Oct 6 05:55 | RZLTIWMRezolute · $377M | Reiterated | Buy | $6.00 | +67.6% | +7.3%next day −0.8% · 5 days +12.0% | ↗ |
| Oct 1on TipRanks Oct 2 06:16 | ORKAIWMOruka Therapeutics · $4.9B | Reiterated | Buy | $151 | +109.9% | 0.0%next day +0.6% · 5 days −8.7% | ↗ |
| Oct 1on TipRanks Oct 2 06:16 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $40.00 | +209.4% | −5.5%next day +6.0% · 5 days +5.1% | ↗ |
| Oct 1on TipRanks Oct 2 06:16 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | $32.00 | +225.9% | −3.7%next day −1.9% · 5 days −3.2% | ↗ |
| Oct 1on TipRanks Oct 2 06:16 | ABVXAbivax SA Sponsored ADR · $8.6B | Reiterated | Buy | $175 | +98.6% | −4.1%next day −3.1% · 5 days −7.7% | ↗ |
| Oct 1on TipRanks 07:30 | LQDAIWMLiquidia Technologies · $3.1B | Downgrade | Hold | — | — | −7.7%next day +1.6% · 5 days −1.2% | ↗ |
| Oct 1on TipRanks 07:30 | UTHRUnited Therapeutics · $23.3B | Upgrade | Buy | $728 | +36.6% | +5.3%next day −5.9% · 5 days −8.1% | ↗ |
| Sep 29on TipRanks Sep 30 06:30 | RNACIWMCartesian Therapeutics · $199M | Reiterated | Buy | $44.00 | +601.8% | +0.6%next day −0.2% · 5 days −8.7% | ↗ |
| Sep 29on TipRanks Sep 30 06:30 | NKTRIWMNektar Therapeutics · $1.3B | Reiterated | Buy | $178 | +397.5% | −1.7%next day +2.4% · 5 days −34.6% | ↗ |
| Sep 25on TipRanks 05:25 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $40.00 | +209.4% | −4.6%next day +1.7% · 5 days +4.9% | ↗ |
| Sep 22on TipRanks Sep 23 05:55 | MAZEIWMMaze Therapeutics, Inc. · $1.5B | Reiterated | Buy | $46.00 | +67.1% | +26.8%next day −0.3% · 5 days −3.6% | ↗ |
| Sep 14on TipRanks Sep 15 06:25 | AKBAIWMAkebia Therapeutics · $193M | Reiterated | Buy | $4.00 | +497.0% | +1.6%next day −5.7% · 5 days −4.4% | ↗ |
| Sep 3on TipRanks 13:35 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | $20.00 → $32.00+60.0% | +225.9% | −4.1%next day +6.8% · 5 days −1.2% | ↗ |
| Aug 27on TipRanks 07:10 | CNTBIWMConnect Biopharma Holdings · $57M | Reiterated | Buy | $10.00 | +1,003.8% | −2.8%next day −2.0% · 5 days −15.6% | ↗ |
| Aug 26on TipRanks 06:55 | SYREIWMSpyre Therapeutics · $7.3B | Assigned | Buy | $132 → $121−8.3% | +51.4% | −12.8%next day −0.6% · 5 days −6.9% | ↗ |
| Aug 12on TipRanks Aug 13 06:25 | LQDAIWMLiquidia Technologies · $3.1B | Reiterated | Buy | $109 → $111+1.8% | +223.1% | −10.8%next day −9.2% · 5 days −3.9% | ↗ |
| Aug 10on TipRanks Aug 11 07:10 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Buy | $30.00 | +214.1% | −5.1%next day −3.9% · 5 days −5.6% | ↗ |
| Aug 10on TipRanks Aug 11 07:10 | JBIOIWMJade Biosciences · $855M | Reiterated | Buy | $74.00 → $77.00+4.1% | +471.6% | −1.0%next day +3.2% · 5 days +8.0% | ↗ |
| Aug 10on TipRanks Aug 11 06:55 | ORKAIWMOruka Therapeutics · $4.9B | Reiterated | Buy | $151 | +109.9% | +6.4%next day −0.1% · 5 days +7.2% | ↗ |
| Aug 6on TipRanks Aug 7 07:10 | AVTXIWMAvalo Therapeutics · $644M | Reiterated | Buy | $58.00 | +414.6% | −0.6%next day −2.6% · 5 days +2.8% | ↗ |
| Aug 5on TipRanks Aug 6 06:05 | INVAIWMInnoviva · $1.5B | Reiterated | Buy | $42.00 | +102.1% | −1.5%next day +3.1% · 5 days +1.1% | ↗ |
| Jun 2on TipRanks 16:00 | RZLTIWMRezolute · $377M | Reiterated | Buy | $5.00 → $6.00+20.0% | +67.6% | +15.2%next day −1.9% · 5 days −13.0% | ↗ |
| Feb 25on TipRanks 20:06 | UTHRUnited Therapeutics · $23.3B | Reiterated | Hold | — | — | −5.3%next day +0.5% · 5 days −2.5% | ↗ |
| Feb 20on TipRanks 06:35 | ARDXIWMArdelyx · $795M | Reiterated | Buy | $17.00 | +450.2% | −15.7%next day +1.4% · 5 days +14.8% | ↗ |
| Nov 4on TipRanks 07:00 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $61.00 | +220.5% | −1.4%next day +7.9% · 5 days +24.9% | ↗ |
| Nov 3on TipRanks Nov 4 10:45 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $82.00 | −36.3% | −3.6%next day +1.9% · 5 days +9.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗